Successful treatment of exfoliative cheilitis with dupilumab: A case report

This case report describes the first known successful treatment of exfoliative cheilitis with the interleukin-4 receptor alpha antagonist dupilumab in an adult patient. With no response to topical tacrolimus, hydrocortisone, dapsone, crisaborole or systemic doxycycline, low dose isotretinoin, or met...

Descripción completa

Detalles Bibliográficos
Autores principales: Cino, Daniela, Gavigan, Genevieve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
JCMS Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408346/
https://www.ncbi.nlm.nih.gov/pubmed/37560382
http://dx.doi.org/10.1177/2050313X231193076
_version_ 1785086167004217344
author Cino, Daniela
Gavigan, Genevieve
author_facet Cino, Daniela
Gavigan, Genevieve
author_sort Cino, Daniela
collection PubMed
description This case report describes the first known successful treatment of exfoliative cheilitis with the interleukin-4 receptor alpha antagonist dupilumab in an adult patient. With no response to topical tacrolimus, hydrocortisone, dapsone, crisaborole or systemic doxycycline, low dose isotretinoin, or methotrexate, she had resolution with off-label dupilumab after 4 months of treatment.
format Online
Article
Text
id pubmed-10408346
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-104083462023-08-09 Successful treatment of exfoliative cheilitis with dupilumab: A case report Cino, Daniela Gavigan, Genevieve SAGE Open Med Case Rep JCMS Case Report This case report describes the first known successful treatment of exfoliative cheilitis with the interleukin-4 receptor alpha antagonist dupilumab in an adult patient. With no response to topical tacrolimus, hydrocortisone, dapsone, crisaborole or systemic doxycycline, low dose isotretinoin, or methotrexate, she had resolution with off-label dupilumab after 4 months of treatment. SAGE Publications 2023-08-07 /pmc/articles/PMC10408346/ /pubmed/37560382 http://dx.doi.org/10.1177/2050313X231193076 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle JCMS Case Report
Cino, Daniela
Gavigan, Genevieve
Successful treatment of exfoliative cheilitis with dupilumab: A case report
title Successful treatment of exfoliative cheilitis with dupilumab: A case report
title_full Successful treatment of exfoliative cheilitis with dupilumab: A case report
title_fullStr Successful treatment of exfoliative cheilitis with dupilumab: A case report
title_full_unstemmed Successful treatment of exfoliative cheilitis with dupilumab: A case report
title_short Successful treatment of exfoliative cheilitis with dupilumab: A case report
title_sort successful treatment of exfoliative cheilitis with dupilumab: a case report
topic JCMS Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408346/
https://www.ncbi.nlm.nih.gov/pubmed/37560382
http://dx.doi.org/10.1177/2050313X231193076
work_keys_str_mv AT cinodaniela successfultreatmentofexfoliativecheilitiswithdupilumabacasereport
AT gavigangenevieve successfultreatmentofexfoliativecheilitiswithdupilumabacasereport

Ejemplares similares